- Price is above the Trend Line, keeping the weekly tape constructive.
- Activity pressure is positive on the latest completed week.
SAGILITY
NSI
Week ended 07 Aug 2026
Weekly Investor Report
Sagility Limited · Healthcare · Health Information Services
Latest close
43.67 INR
0.9%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is 2.0% above the Trend Line and sits at 35.6% of its 52-week range. The latest completed week returned 0.9%, after a 2.9% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 61/100.
Setup score
48
out of 100
Latest Close
43.67 INR
7 Aug 2026
1W Return
0.9%
latest completed week
4W Return
2.9%
short-term follow-through
12W Return
4.0%
quarterly tape
Trend Breadth
46.2%
24 of 52 weeks active
Volume Ratio
1.0x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is weak, so confirmation is not yet broad enough.
- The share remains more than 20% below its 52-week high.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
0.9%
Latest completed week; four-week move 2.9%.
Indicator stack
25/100
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
61/100
31 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is 2.0% above the Trend Line and sits at 35.6% of its 52-week range. The latest completed week returned 0.9%, after a 2.9% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.0x the 13-week average. Participation is around or above normal and provides reasonable confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.1012-week average 0.11
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure9/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.10Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 2.9% over four weeks, 4.0% over 12 weeks, and -3.3% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year24
Trend breadth46.2%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.72Latest activity-pressure read.
Pressure change495.6%Four-week change in activity pressure.
Leadership-2.06Latest relative-leadership reading.
RS change43.8%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is neither clearly cheap nor expensive.
Factor week 09 Aug 2026
Financial statements through 31 Mar 2026
Field coverage 94%
Model confidence 88%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength86/100Blend of value, momentum, and quality. Underlying universe rank 15; rank 1 is best.
Value78/100Relative valuation strength. Underlying universe rank 23; rank 1 is best.
Quality85/100Profitability and accounting quality. Underlying universe rank 16; rank 1 is best.
Momentum36/100Medium-term price momentum. Underlying universe rank 65; rank 1 is best.
Growth93/100Revenue and earnings growth. Underlying universe rank 8; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Value-quality framework77/100Value and quality alignment from the Sharemaestro SVQF framework.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- 23.9x Price divided by trailing earnings.
- Price / sales
- 2.9x Market value relative to trailing revenue.
- EV / EBITDA
- 12.2x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- 4.8% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 37.2% Gross profit retained from each unit of revenue.
- Operating margin
- 17.4% Operating profit retained from revenue.
- Free-cash-flow margin
- 14.2% Free cash flow generated from revenue.
- Return on invested capital
- 8.9% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 29.1% Latest one-year revenue growth.
- EPS growth
- 71.5% Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- -7.2% Latest one-year free-cash-flow growth.
- Piotroski F-score
- 7/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- 0.3% Cash dividends relative to market value.
- Buyback yield
- 0.0% Net share repurchases relative to market value.
- Shareholder yield
- 0.3% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 0.4x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment61/100
Weighted news tone is neutral across 31 relevant articles.
14 positive · 15 neutral · 2 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-24.5%Distance below the 52-week high.
13-week volatility3.2%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher12 of 2614 weeks finished lower.
Best week+7.4%Week of 31 Jul.
Worst week-11.8%Week of 27 Feb.
Latest week+0.9%Week of 7 Aug.
Shape of recent returns
Strong gains3
Modest gains9
Flat weeks0
Modest losses11
Sharp losses3
Recent vol3.2%13-week weekly-return volatility.
Base vol4.3%52-week weekly-return volatility.
Up/down split26/26Count of positive and negative weeks in the 52-week window.
Average skew3.5% / -3.5%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorIN Healthcare
4-week rank36 / 100
Group average1.2%
Trend breadth83.0%
Trend83.0%active weekly trend signals
MD85.0%positive activity pressure
RS73.0%positive relative leadership
Four-week leaders
IndustryIN Health Information Services
4-week rank2 / 4
Group average-1.2%
Trend breadth50.0%
Trend50.0%active weekly trend signals
MD100.0%positive activity pressure
RS50.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape46/100
Trend, activity pressure, participation, and risk combine to a 46/100 tape read.
Indicator analysis26/100Latest 12-week confirmation: trend 0/12, activity pressure 9/12, relative leadership 0/12.
Activity pressure 0.10; No reversal markers Factors72/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 54; Small Cap Core rank 40 SVQF77/100Value and quality alignment from the Sharemaestro SVQF framework.
Composite rank 357.0 of 1576 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment61/100Weighted news tone is neutral across 31 relevant articles.
Pros and Cons of Investing in Sagility Ltd Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 43.67 INR | 0.9% | 42.79 INR | 44.18 INR | 0.72 | -2.06 | 81.8M | Off |
| 31 Jul 2026 | 43.30 INR | 7.4% | 43.01 INR | 44.19 INR | 0.69 | -2.22 | 313.2M | Off |
| 24 Jul 2026 | 40.33 INR | -3.2% | 43.33 INR | 44.20 INR | 0.32 | -6.62 | 110.3M | Off |
| 17 Jul 2026 | 41.65 INR | -1.8% | 43.74 INR | 44.24 INR | 0.27 | -5.87 | 88.9M | Off |
| 10 Jul 2026 | 42.43 INR | 3.8% | 44.09 INR | 44.27 INR | 0.12 | -3.66 | 149.4M | Off |
| 3 Jul 2026 | 40.89 INR | 1.3% | 44.33 INR | 44.30 INR | -0.10 | -7.44 | 16.0M | Off |
| 26 Jun 2026 | 40.37 INR | 2.2% | 44.61 INR | 44.34 INR | -0.02 | -7.79 | 0 | Off |
| 19 Jun 2026 | 39.49 INR | -2.4% | 44.94 INR | 44.38 INR | 0.00 | -9.59 | 23.2M | Off |
| 12 Jun 2026 | 40.47 INR | 1.1% | 45.23 INR | 44.44 INR | 0.01 | -5.77 | 16.0M | Off |
| 5 Jun 2026 | 40.02 INR | -2.5% | 45.66 INR | 44.49 INR | 0.01 | -5.65 | 10.1M | Off |
| 29 May 2026 | 41.04 INR | -0.5% | 46.05 INR | 44.55 INR | 0.00 | -3.83 | 40.7M | Off |
| 22 May 2026 | 41.24 INR | -1.8% | 46.43 INR | 44.59 INR | -0.21 | -3.91 | 79.9M | Off |
| 15 May 2026 | 42.00 INR | -5.0% | 46.64 INR | 44.63 INR | -0.45 | -1.79 | 143.1M | Off |
| 8 May 2026 | 44.19 INR | 5.9% | 46.75 INR | 44.67 INR | -0.66 | 0.95 | 98.1M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.